Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
Human Molecular Genetics|February 4, 2017
Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucomaJeffrey O'Callaghan, Darragh E Crosbie, Paul S Cassidy, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 20, 2023
Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer RegistryVania Balderrama-Brondani, Allison M Griffin, Taylor J Owen, et al.
Diabetes|January 25, 2014
Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammationGraham A Tynan, Claire H Hearnden, Ewa Oleszycka, et al.
Journal for Immunotherapy of Cancer|September 20, 2019
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinomaMouhammed Amir Habra, Bettzy Stephen, Matthew Campbell, et al.
Epilepsia|November 6, 2024
Imaging blood-brain barrier dysfunction in drug-resistant epilepsy: A multi-center feasibility studyNir Cafri, Sheida Mirloo, Daniel Zarhin, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Nature Communications|May 24, 2012
Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injuryMatthew Campbell, Finnian Hanrahan, Oliviero L Gobbo, et al.
Nature Communications|April 15, 2022
Microvascular stabilization via blood-brain barrier regulation prevents seizure activityChris Greene, Nicole Hanley, Cristina R Reschke, et al.
JCI Insight|August 9, 2019
Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophyNatalie Hudson, Lucia Celkova, Alan Hopkins, et al.
Journal of Medicinal Chemistry|January 9, 2025
Phenotype-Led Identification of IL-10 Upregulators in Human CD4+ T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 InhibitorsSimon Nicolle, Mike Barker, John Barrett, et al.
Pageof 29